Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanLifestyle changes in women with polycystic ovary syndromeLifestyle changes in women with polycystic ovary syndromeRole of therapeutic fasting in women's health: An overviewComplications and challenges associated with polycystic ovary syndrome: current perspectivesPregnancy complications in women with polycystic ovary syndromePolycystic ovary syndrome: do endocrine-disrupting chemicals play a role?CLINICAL PRACTICE. Polycystic Ovary Syndrome.Childhood obesity and its impact on the development of adolescent PCOS.Predictors of pregnancy in women with polycystic ovary syndrome.Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight femalesDirect effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.Optimal management of subfertility in polycystic ovary syndrome.Children's Hospital Association consensus statements for comorbidities of childhood obesityTreatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study.Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates.Aerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition.The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinthLongterm management of Polycystic Ovarian Syndrome (PCOS)Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot StudyAssessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot studyRelationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United StatesWeight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescentsGenetics of the polycystic ovary syndrome.Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study.Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan.Clinical review: Adolescent anovulation: maturational mechanisms and implications.Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction.Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study.Effects of tanshinone on hyperandrogenism and the quality of life in women with polycystic ovary syndrome: protocol of a double-blind, placebo-controlled, randomised trial.Exercise in obese female rats has beneficial effects on maternal and male and female offspring metabolism.Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis.Hormonal and metabolic effects of polyunsaturated fatty acid (omega-3) on polycystic ovary syndrome induced rats under diet.Polycystic ovary syndrome and weight management.Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome.
P2860
Q21245262-6E152A7D-A2ED-48CE-BE9A-D1281F0D70D4Q24234000-3855F2C8-4C97-4A63-94A8-6D92E7D89D6CQ24235398-32C51E3A-1C9D-4B4D-B99D-F5321F85D85FQ26738683-67826CF0-133C-47E7-82CA-27FBAC481929Q26799566-8186BBFA-4AEF-4A45-B864-B2E5BC55CB0CQ26822402-0B71B7C1-D3CB-4717-A621-8797339B037EQ26829866-91CAD10D-B469-4CDD-8B20-0D9AEC77FC0EQ29248890-3D132CE6-5A27-4565-B19D-61654D10CF2BQ30405587-40E38C7B-643E-4988-AED0-9C74A0DA154CQ30434932-C030F966-F612-46AE-9EED-16487D3E8C28Q33587839-00EA73F2-BBF5-4098-8994-9C9E0A8B97E4Q33634370-861B140F-775E-44DD-B333-56EAF450D31EQ33675285-1386EC12-8E81-47D7-9DF0-39CAD04D2DDAQ33779073-280AE00A-D98D-425E-A8E4-823D894C83A7Q33997334-79476DD6-D9B7-40F4-81E0-8CCD52CA62D8Q34622523-E37D2C62-BB65-4A04-8BA5-17A9D1D70719Q34777753-171C5042-570A-4ED5-82E5-67793AC45818Q34975539-15E71680-F775-444B-B2B1-3B881F2625CAQ35046136-553188AB-F98A-42FB-96FD-E1E6DEF8A916Q35100131-7E700999-7990-4F68-AB0E-8ACE52DFDAA9Q35100161-B4A0BB82-0E19-4D6B-9E94-17BFA9693932Q35200094-D7606973-CB1E-492A-A586-64923DDD9472Q35787725-1895C6E9-6324-49A1-A905-EA47C9AE588EQ35813456-B090D2FD-A8A1-4CC8-9526-4D58151DB009Q36100596-87D1CE81-5B3B-45D3-88FD-EB95512C5633Q36176816-BE571571-B3DD-4432-904D-871EA8B34015Q36360786-918B33FA-D210-435E-BC91-6816E8F41C46Q36421543-D339B728-8CB3-452E-B0AC-F7E4AF1B4235Q36721767-438E98CA-B422-4FAE-B8A2-508E342FF1D0Q36741706-D0AD0919-F547-4BBF-AE38-3DD0B529E172Q36963947-9976C1FA-1A77-4E24-8F47-254AA3DC5832Q37149593-53D99840-D73C-4657-9083-22514CD2422FQ37173546-7D090FB9-7F0B-4507-927B-52AD20EB3A18Q37197400-8B8EEEB8-DD55-4638-B40B-2DF0DCE3CF2FQ37256452-070224AA-74A9-4D60-BFE1-1AF3C5C84A24Q37587083-24255D91-7095-45A0-A519-CFE86B2C4ED5Q37609209-4329ECB1-1E2B-4396-8D97-3D3453EA1917Q37686554-7554FF71-3600-4DCA-98B3-2069FCC1CBC3Q37699367-12E22D5F-F066-45BA-972B-B21B82C5C99EQ37723627-07BB4275-04F2-4B25-9AC3-D0E13CB9C0A2
P2860
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of obesity in polycy ...... cystic Ovary Syndrome Society.
@en
Treatment of obesity in polycy ...... cystic Ovary Syndrome Society.
@nl
type
label
Treatment of obesity in polycy ...... cystic Ovary Syndrome Society.
@en
Treatment of obesity in polycy ...... cystic Ovary Syndrome Society.
@nl
prefLabel
Treatment of obesity in polycy ...... cystic Ovary Syndrome Society.
@en
Treatment of obesity in polycy ...... cystic Ovary Syndrome Society.
@nl
P50
P1476
Treatment of obesity in polycy ...... ycystic Ovary Syndrome Society
@en
P2093
Kathleen M Hoeger
Renato Pasquali
P304
P356
10.1016/J.FERTNSTERT.2008.09.018
P407
P577
2008-12-04T00:00:00Z